| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |